by Brad N. Taylor, Ph.D. | Feb 28, 2022
Krakatoa’s point of use media manufacturing reduces greenhouse gas emissions by 65% per unit of media produced. (San Diego, CA – February 28, 2022) Nucleus Biologics, The Cell Performance Company™, is proud to announce the launch of Krakatoa™, an innovative,...
by Brad N. Taylor, Ph.D. | Jan 20, 2022
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a collaboration agreement on custom media formulation and...
by Brad N. Taylor, Ph.D. | Dec 14, 2021
NB-AIR™ Artificial Intelligence Research platform recognized with prestigious Pharma and Biotech innovation award Nucleus Biologics is pleased to announce that its NB-AIR™ Artificial Intelligence Research platform was selected as the winner of this year’s Fierce...
by Rachel Gauvin | Jun 21, 2021
We are honored to be featured in an interview with Bioinformant! Disrupting the Cell Therapy Market: Nucleus Biologics Brings Transparency, Customization & Control In recent years, the cell culture company Nucleus Biologics has been at the forefront...
by Dr. Alyssa Master | May 27, 2020
SAN DIEGO, May 27, 2020 — Nucleus Biologics, a leader in precision cell culture, today announced the availability of NB-Lux™, an online configuration and ordering platform for cell culture media. Designed for developers of cell therapies, NB-Lux™ speeds...
by Dr. Alyssa Master | Aug 5, 2019
Nucleus Biologics™ now has the leading xeno-free, recombinant, extracellular matrix SAN DIEGO – August 6, 2019 – Nucleus Biologics™, a leader in precision cell culture, is pleased to announce the acquisition of Primorigen Biosciences, Inc. The addition...